{"id":565923,"date":"2026-09-10T04:00:00","date_gmt":"2026-09-10T02:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/find-ckd-et-flow-des-benefices-pour-lensemble-dune-population-heterogene-de-patients\/"},"modified":"2026-09-16T22:48:13","modified_gmt":"2026-09-16T20:48:13","slug":"find-ckd-et-flow-des-benefices-pour-lensemble-dune-population-heterogene-de-patients","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/find-ckd-et-flow-des-benefices-pour-lensemble-dune-population-heterogene-de-patients\/","title":{"rendered":"FIND-CKD et FLOW : des b\u00e9n\u00e9fices pour l’ensemble d’une population h\u00e9t\u00e9rog\u00e8ne de patients"},"content":{"rendered":"\n

Chez les adultes non diab\u00e9tiques atteints d’insuffisance r\u00e9nale chronique (IRC), le fin\u00e9r\u00e9none a entra\u00een\u00e9 un ralentissement significatif de la d\u00e9t\u00e9rioration de la fonction r\u00e9nale et a \u00e9galement r\u00e9duit le risque de complications cardiovasculaires , comme le montrent les donn\u00e9es r\u00e9cemment publi\u00e9es de l\u2019\u00e9tude FIND-CKD. Des analyses r\u00e9centes de l\u2019\u00e9tude FLOW ont r\u00e9v\u00e9l\u00e9 que le semaglutide am\u00e9liorait de mani\u00e8re significative la qualit\u00e9 de vie li\u00e9e \u00e0 la sant\u00e9 chez les adultes atteints de diab\u00e8te de type 2 et souffrant d\u2019une IRC. Ces r\u00e9sultats d\u2019\u00e9tude constituent une nouvelle lueur d\u2019espoir pour les personnes atteintes de MRC.<\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Chez les adultes non diab\u00e9tiques atteints d’insuffisance r\u00e9nale chronique (IRC), le fin\u00e9r\u00e9none a entra\u00een\u00e9 un ralentissement significatif de la d\u00e9t\u00e9rioration de la fonction r\u00e9nale et a \u00e9galement r\u00e9duit le risque……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":565927,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"CKD : b\u00e9n\u00e9fices cardior\u00e9naux des nsMRA et des GLP-1RA ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11549,11378,11404,11527,11315,11434,11535],"tags":[101012,12826,22514,101011,94725,68015,66549,101009,17458],"powerkit_post_featured":[],"class_list":["post-565923","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-cardiologie","category-endocrinologie-et-diabetologie","category-etudes","category-medecine-interne-generale","category-nephrologie-fr","category-rapports-de-congres","tag-benefice-cardio-renal","tag-ckd-fr","tag-diabetique","tag-etude-find-ckd","tag-etude-flow","tag-finerenon-fr","tag-non-diabetiques","tag-nsmra","tag-semaglutid-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-24 13:10:07","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":565939,"slug":"find-ckd-e-flow-benefici-in-una-popolazione-eterogenea-di-pazienti","post_title":"FIND-CKD e FLOW: benefici in una popolazione eterogenea di pazienti","href":"https:\/\/medizinonline.com\/it\/find-ckd-e-flow-benefici-in-una-popolazione-eterogenea-di-pazienti\/"},"pt_PT":{"locale":"pt_PT","id":565944,"slug":"find-ckd-e-flow-beneficios-em-populacoes-heterogeneas-de-doentes","post_title":"FIND-CKD e FLOW: benef\u00edcios em popula\u00e7\u00f5es heterog\u00e9neas de doentes","href":"https:\/\/medizinonline.com\/pt-pt\/find-ckd-e-flow-beneficios-em-populacoes-heterogeneas-de-doentes\/"},"es_ES":{"locale":"es_ES","id":565949,"slug":"find-ckd-y-flow-beneficios-en-poblaciones-de-pacientes-heterogeneas","post_title":"FIND-CKD y FLOW: beneficios en poblaciones de pacientes heterog\u00e9neas","href":"https:\/\/medizinonline.com\/es\/find-ckd-y-flow-beneficios-en-poblaciones-de-pacientes-heterogeneas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/565923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=565923"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/565923\/revisions"}],"predecessor-version":[{"id":565931,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/565923\/revisions\/565931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/565927"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=565923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=565923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=565923"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=565923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}